Five things for pharma marketers to know: Wednesday, July 27, 2016

Photo credit: James Gathany

1. IBM will provide technology and resources to a Brazilian research foundation to help track the spread of the Zika virus. The Oswaldo Cruz Foundation plans to use the technology to analyze data about travel patterns. (Reuters)

2. Sen. Charles Grassley (R-Iowa) is investigating whether the Medicare Part D prescription program "is free from exploitation." His inquiry follows a report in The Associated Press that found spending on high-cost drugs jumped 85% in three years. (AP)

3. Eli Lilly CEO John Lechleiter will retire later this year and be succeeded by David Ricks, SVP and president of Lilly's bio medicines business. The drugmaker, which announced its second-quarter results on Tuesday, exceeded analysts' earnings expectations. (Reuters)

4. Howard Dean, chairman of the Democratic National Committee, urged support for Hillary Clinton's healthcare plan, including her goal of driving down prescription drug costs. (Politico)

5. The government website that provides information about clinical trials,, does not require trial sponsors to disclose charges to patients. One patient would have had to pay $14,000 to participate in a stem-cell therapy trial. (California Healthline)